N‐Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice
- 31 March 2008
- journal article
- Published by Wiley in The Journal of Physiology
- Vol. 586 (7), 2003-2014
- https://doi.org/10.1113/jphysiol.2007.148338
Abstract
Duchenne muscular dystrophy (DMD) is a severe degenerative muscle disease caused by a mutation in the gene encoding dystrophin, a protein linking the cytoskeleton to the extracellular matrix. In this study we investigated whether the antioxidant N-acetylcysteine (NAC) provided protection against dystrophic muscle damage in the mdx mouse, an animal model of DMD. In isolated mdx muscles, NAC prevented the increased membrane permeability and reduced the force deficit associated with stretch-induced muscle damage. Three-week-old mdx mice were treated with NAC in the drinking water for 6 weeks. Dihydroethidium staining showed that NAC treatment reduced the concentration of reactive oxygen species (ROS) in mdx muscles. This was accompanied by a significant decrease in centrally nucleated fibres in muscles from NAC-treated mdx mice. Immunoblotting showed that NAC treatment decreased the nuclear protein expression of NF-kappaB, a transcription factor involved in pro-inflammatory cytokine expression. Finally, we show that NAC treatment reduced caveolin-3 protein levels and increased the sarcolemmal expression of beta-dystroglycan and the dystrophin homologue, utrophin. Taken together, our findings suggest that ROS play an important role in the dystrophic pathogenesis, both in terms of activating damage pathways and in regulating the expression of some dystrophin-associated membrane proteins. These results offer the prospect that antioxidants such as NAC could have therapeutic potential for DMD patients.Keywords
This publication has 52 references indexed in Scilit:
- Reactive oxygen species contribute to Ca2+ signals produced by osmotic stress in mouse skeletal muscle fibresThe Journal of Physiology, 2008
- The role of reactive oxygen species in the hearts of dystrophin-deficient mdx miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Modulation of p38 Mitogen-Activated Protein Kinase Cascade and Metalloproteinase Activity in Diaphragm Muscle in Response to Free Radical Scavenger Administration in Dystrophin-Deficient Mdx MiceThe American Journal of Pathology, 2007
- Selective fluorescent imaging of superoxide in vivo using ethidium-based probesProceedings of the National Academy of Sciences of the United States of America, 2006
- Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFα function with Etanercept in mdx miceNeuromuscular Disorders, 2006
- N‐acetylcysteine attenuates the decline in muscle Na+,K+‐pump activity and delays fatigue during prolonged exercise in humansThe Journal of Physiology, 2006
- Role of reactive oxygen species in contraction‐mediated glucose transport in mouse skeletal muscleThe Journal of Physiology, 2006
- Tyrosine Phosphorylation of Caveolin 1 by Oxidative Stress Is Reversible and Dependent on the c-src Tyrosine Kinase but Not Mitogen-Activated Protein Kinase Pathways in Placental Artery Endothelial Cells1Biology of Reproduction, 2005
- Pharmacological strategies for muscular dystrophyNature Reviews Drug Discovery, 2003
- Increased Number of Caveolae and Caveolin-3 Overexpression in Duchenne Muscular DystrophyBiochemical and Biophysical Research Communications, 1999